1
|
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
|
Nat Med
|
2011
|
6.35
|
2
|
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
|
J Am Soc Nephrol
|
2005
|
2.00
|
3
|
Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts.
|
Crit Care
|
2012
|
1.90
|
4
|
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
|
J Am Soc Nephrol
|
2005
|
1.74
|
5
|
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid.
|
Mol Cancer Ther
|
2008
|
1.09
|
6
|
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
|
J Am Soc Nephrol
|
2005
|
1.07
|
7
|
Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
|
Transplantation
|
2015
|
1.05
|
8
|
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.
|
J Am Soc Nephrol
|
2006
|
1.05
|
9
|
Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.
|
Am J Physiol Renal Physiol
|
2002
|
1.04
|
10
|
Color doppler ultrasonography in the diagnostic evaluation of renal allografts.
|
Nephron Clin Pract
|
2006
|
0.96
|
11
|
Kidney transplantation across HLA and ABO antibody barriers.
|
Curr Opin Organ Transplant
|
2013
|
0.96
|
12
|
Late referral--a major cause of poor outcome in the very elderly dialysis patient.
|
Nephrol Dial Transplant
|
2006
|
0.95
|
13
|
Aquaporin-1 channel function is positively regulated by protein kinase C.
|
J Biol Chem
|
2007
|
0.89
|
14
|
Real-time contrast-enhanced sonography in renal transplant recipients.
|
Clin Transplant
|
2006
|
0.86
|
15
|
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function.
|
Nephrol Dial Transplant
|
2007
|
0.86
|
16
|
Salt--a potential 'uremic toxin'?
|
Blood Purif
|
2006
|
0.86
|
17
|
The long-term consequences of living-related or unrelated kidney donation.
|
Nephrol Dial Transplant
|
2004
|
0.86
|
18
|
Bleeding complications in pediatric ABO-incompatible kidney transplantation.
|
Pediatr Nephrol
|
2012
|
0.86
|
19
|
RAGE expression in the human peritoneal membrane.
|
Nephrol Dial Transplant
|
2008
|
0.85
|
20
|
Role and Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation.
|
Transfus Med Hemother
|
2013
|
0.83
|
21
|
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
|
Transplantation
|
2015
|
0.82
|
22
|
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
|
Transplantation
|
2015
|
0.82
|
23
|
Protocol biopsy: what is the rationale and what is the evidence?
|
Nephrol Dial Transplant
|
2003
|
0.81
|
24
|
Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
|
Atheroscler Suppl
|
2013
|
0.81
|
25
|
A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function.
|
Clin Chem Lab Med
|
2016
|
0.81
|
26
|
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography.
|
Transplantation
|
2012
|
0.80
|
27
|
Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus.
|
Transplantation
|
2009
|
0.80
|
28
|
An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients.
|
Nephrol Dial Transplant
|
2005
|
0.79
|
29
|
Immunoadsorption in nephrology and kidney transplantation.
|
Nephrol Dial Transplant
|
2010
|
0.79
|
30
|
Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients.
|
Transplantation
|
2013
|
0.78
|
31
|
Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysis.
|
Curr Pharm Des
|
2014
|
0.78
|
32
|
The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial.
|
Trials
|
2014
|
0.77
|
33
|
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft.
|
Transplantation
|
2005
|
0.77
|
34
|
Cellular infiltrates and NFκB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance.
|
Transplantation
|
2012
|
0.77
|
35
|
The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys.
|
Cell Tissue Res
|
2014
|
0.77
|
36
|
Psychosocial and physical outcome following kidney donation-a retrospective analysis.
|
Transpl Int
|
2015
|
0.77
|
37
|
Intestinal transplantation: review of operative techniques.
|
Clin Transplant
|
2013
|
0.77
|
38
|
Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.
|
Clin Transplant
|
2013
|
0.77
|
39
|
The role of pretransplant dialysis modality on renal allograft outcome.
|
Nephrol Dial Transplant
|
2011
|
0.76
|
40
|
Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
|
Transplantation
|
2009
|
0.75
|
41
|
Authors' response.
|
Crit Care
|
2013
|
0.75
|
42
|
Desensitization of HLA-incompatible kidney recipients.
|
N Engl J Med
|
2011
|
0.75
|
43
|
Expanding the indications of pancreas transplantation alone.
|
Pancreas
|
2014
|
0.75
|
44
|
Pulmonary cavernae in Wegener's granulomatosis.
|
Nephrol Dial Transplant
|
2006
|
0.75
|
45
|
Emerging drugs for the treatment of transplant rejection.
|
Expert Opin Emerg Drugs
|
2011
|
0.75
|
46
|
A generalized seizure in a renal allograft recipient.
|
Nephrol Dial Transplant
|
2005
|
0.75
|
47
|
Improved pulse wave velocity and renal function in individualized calcineurin-inhibitor treatment by immunomonitoring: the randomized controlled Calcineurin Inhibitor-Sparing (CIS) Trial.
|
Transplantation
|
2017
|
0.75
|
48
|
Long-Term Follow-Up of Kidney Transplant Recipients With Polycystic Kidney Disease.
|
Exp Clin Transplant
|
2015
|
0.75
|
49
|
Use of erythropoietin after solid organ transplantation.
|
Nephrol Dial Transplant
|
2007
|
0.75
|
50
|
Lymphoid interstitial lung disease in a patient with acute tubulointerstitial nephritis and uveitis: a new facet of a rare syndrome?
|
Am J Kidney Dis
|
2006
|
0.75
|
51
|
Correction: Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
|
PLoS One
|
2017
|
0.75
|
52
|
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis--is it the only cause?
|
Nephrol Dial Transplant
|
2007
|
0.75
|
53
|
Current pharmacotherapeutical options for the prevention of kidney transplant rejection.
|
Expert Opin Pharmacother
|
2013
|
0.75
|
54
|
Transplantation in type 1 diabetes.
|
Nephrol Dial Transplant
|
2009
|
0.75
|